Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	10/28/2011 5:25:16 PM
	of 3027

4:50PM Momenta Pharma is trading 18.5% higher after hours at $14.50 (see 16:48 comment) ( MNTA) 12.24 -0.06 : 4:48PM Momenta Pharmaceuticals obtains preliminary injunction against Amphastar Pharmaceuticals, Watson Pharmaceuticals and International Medical Systems ( MNTA) 12.24 -0.06 : Co announced that the United States District Court for the District of Massachusetts entered an order enjoining Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International Medical Systems, Ltd. from offering to sell or selling their generic Lovenox before the District Court renders a decision in the on-going litigation relating to the U.S. Patent No. 7,575,886. No trial date has been set. In granting the motion, the District Court found that Momenta Pharmaceuticals demonstrated a reasonable likelihood of success on the merits of their claim that Patent No. 7,575,886 is valid and infringed by the competitor's enoxaparin sodium product. The grant of the preliminary injunction is subject to appeal.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next